Straumann, Nobel Report Q1 Earnings
The start of 2008 brought good news for Straumann and not so good news for Nobel Biocare. Straumann reported 12% sales growth but still missed expectations slightly. Nobel reported a 25% decline in reported profit citing a weak US dollar. Shares of Nobel have been down while Straumann has seen a rise in their share price.
The implant marketplace is much more crowded than it was five years ago. In another three, we’ll still see tremendous growth. The era of consolidation hasn’t really started in the dental implant market - there’s too much opportunity for growth. Yes - Nobel recently bought a small implant company but I believe (and others too) that it was mostly to cover their bases since AlphaBioTec’s implant design was the first generation soon-to-roll-out NobelActive. The real mixing of business is happening between CAD/CAM businesses and the implant makers.
The URI to TrackBack this entry is: http://implantblog.wordpress.com/2008/04/29/straumann-nobel-report-q1-earnings/trackback/
Hey Teresa — I’m a fan of Nobel (also use Straumann and others). Nobel has made a decided turn to hard marketing in the last couple of years compared to the days of Ingmar Branemark and I wonder whether it’s the week US dollar or the new direction. Still a fan but…..
http://www.waittimes.blogspot.com
Hi there Ian - Nobel’s still the market giant but there’s just simply too much competition. IMO too many general dentists associate Nobel with specialists and high prices. And there’s plenty of smaller implant companies that are happy to court the general practices. I’m curious to see how they do in ‘08 - this economy isn’t good for any of us…from dentists to equipment dealers to blog authors